| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8d191df2a239d8ebabcdd5981838060 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1658
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0075 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09H9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-78 |
| filingDate |
2007-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2088e30de32ba8ae1178df1f45bb3a71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49aefecfc30a52bf32fba8a0eff52900
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24cebb561745bbadd2fc5f299c510a99 |
| publicationDate |
2007-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2007297401-A |
| titleOfInvention |
RGD-enriched gelatin-like protein with enhanced cell binding |
| abstract |
A gelatin-like protein with enhanced cell binding properties is provided. An RGD-enriched gelatin having an even distribution of RGD (arginine-glycine-aspartic acid) sequences compared to natural gelatin and having a minimal level of RGD sequences. Specifically, if the ratio of RGD sequence to the total number of amino acids is at least 0.4 and the RGD-enriched gelatin contains 350 or more amino acids, each stretch of 350 amino acids contains at least one RGD motif. The RGD-enriched gelatin is suitable for coating a cell culture support for growing anchor-dependent cells and is used as a component of medical applications, particularly coatings for implants or transplant materials and drug delivery systems. Can do. [Selection figure] None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017183710-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020184975-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019087650-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200060497-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102476632-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2017183710-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11033660-B2 |
| priorityDate |
2003-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |